Tendon and ligament: Development, repair and disease

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 75, Issue 3, 2005, Pages 226-236

  Tozer, Samuel ^a   Duprez, Delphine ^a,b  

^a Université René Descartes   (France)

^b CNRS   (France)

Author keywords

Development; Fgf; Human disease; Ligament; Repair; Tendon

Indexed keywords

FIBROBLAST GROWTH FACTOR;

BIOMECHANICS; EMBRYO DEVELOPMENT; EXTRACELLULAR MATRIX; FIBROBLAST; GENETIC DISORDER; LIGAMENT; LIGAMENT DISEASE; LIGAMENT INJURY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TENDON; TENDON DISEASE; TISSUE INJURY; TISSUE REPAIR; VISCOELASTICITY; WATER CONTENT;

BIOMECHANICS; CONNECTIVE TISSUE; CULTURE TECHNIQUES; EMBRYO; FIBROBLAST GROWTH FACTORS; FIBROBLASTS; HUMANS; LIGAMENTS; LIGAMENTS, ARTICULAR; MODELS, BIOLOGICAL; SYNOVIAL FLUID; TENDON INJURIES; TENDONS; TENSILE STRENGTH; TRANSCRIPTION FACTORS; WATER; WOUND HEALING;

EID: 26844499855     PISSN: 1542975X     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrc.20049     Document Type: Review

References (122)

1. Amthor H, Christ B, Weil M, Patel K. 1998. The importance of timing differentiation during limb muscle development. Curr Biol 8:642-652.
2. Archer CW, Dowthwaite GP, Francis-West P. 2003. Development of synovial joints. Birth Defects Res C Embryo Today 69: 144-155.
3. Asou Y, Nifuji A, Tsuji K, et al. 2002. Coordinated expression of scleraxis and Sox9 genes during embryonic development of tendons and cartilage. J Orthop Res 20:827-833.
4. Barry FP, Murphy JM. 2004. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36:568-584.
5. Bastow ER, Lamb KJ, Lewthwaite JC, et al. 2005. Selective activation of the MEK-ERK pathway is regulated by mechanical stimuli in forming joints and promotes pericellular matrix formation. J Biol Chem 280:11749-11758.
6. Battegay EJ, Rupp J, Iruela-Arispe L, et al. 1994. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors. J Cell Biol 125:917-928.
7. BeckerS, Pasca G, Strumpf D, et al. 1997. Reciprocal signaling between Drosophila epidermal muscle attachment cells and their corresponding muscles. Development 124:2615-2622.
8. Beighton P, De Paepe A, Steinmann B, et al. 1998. Ehlers-Danlossyndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 77:31-37.
9. Benjamin M, Ralphs JR. 2000. The cell and developmental biology of tendons and ligaments. Int Rev Cytol 196:85-130.
10. Bi W, Deng JM, Zhang Z, et al. 1999. Sox9 is required for cartilage formation. Nat Genet 22:85-89.
11. Birk DE, Fitch JM, Babiarz JP, et al. 1990. Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. J Cell Sci 95:649-657.
12. Birk DE, Mayne R. 1997. Localization of collagen types I, III and V during tendon development. Changes in collagen types I and III are correlated with changes in fibril diameter. Eur J Cell Biol 72:352-361.
13. Boileau C, Jondeau G, Mizuguchi T, Matsumoto N. 2005. Molecular genetics of Marfan syndrome. Curr Opin Cardiol 20:194-200.
14. Bonnin MA, Laclef C, Blaise R, et al. 2005. Six1 is not involved in limb tendon development, but is expressed in limb connective tissue under Shh regulation. Mech Dev 122:573-585.
15. Brent AE, Schweitzer R, Tabin CJ. 2003. A somitic compartment of tendon progenitors. Cell 113:235-248.
16. Brent AE, Tabin CJ. 2004. FGF acts directly on the somitic tendon progenitors through the Ets transcription factors Pea3 and Erm to regulate scleraxis expression. Development 131:3885-3896.
17. Brent AE, Braun T, Tabin CJ. 2005. Genetic analysis of interactions between the somitic muscle, cartilage and tendon cell lineages during mouse development. Development 132:515-528.
18. Brunet LJ, McMahon JA, McMahon AP, Harland RM. 1998. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280: 1455-1457.
19. Burch GH, Gong Y, Liu W, et al. 1997. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet 17: 104-108.
20. Byers PH, Duvic M, Atkinson M, et al. 1997. Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen. Am J Med Genet 72:94-105.
21. Chan BP, Fu S, Qin L, et al. 2000. Effects of basic fibroblast growth factor (bFGF) on early stages of tendon healing: a rat patellar tendon model. Acta Orthop Scand 71:513-518.
22. Chang J, Most D, Thunder R, et al. 1998. Molecular studies in flexor tendon wound healing: the role of basic fibroblast growth factor gene expression. J Hand Surg [Am] 23:1052-1058.
23. Chevallier A, Kieny M, Mauger A. 1977. Limb-somite relationship: origin of the limb musculature. J Embryol Exp Morphol 41:245-258.
24. Chevallier A, Kieny M. 1982. On the role of the connective tissue in the patterning of the chick limb musculature. Wilhem Roux Arch 191:277-280.
25. Chhabra A, Tsou D, Clark RT, et al. 2003. GDF-5 deficiency in mice delays Achilles tendon healing. J Orthop Res 21: 826-835.
26. Clark RT, Johnson TL, Schalet BJ, et al. 2001. GDF-5 deficiency in mice leads to disruption of tail tendon form and function. Connect Tissue Res 42:175-186.
27. Colige A, Sieron AL, Li SW, et al. 1999. Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene. Am J Hum Genet 65:308-317.
28. Crossley PH, Minowada G, MacArthur CA, Martin GR. 1996. Roles for FGF8 in the induction, initiation, and maintenance of chick limb development. Cell 84:127-136.
29. D'Souza D, Patel K. 1999. Involvement of long- and short-range signalling during early tendon development. Anat Embryol (Berl) 200:367-375.
30. Deckers MM, van Bezooijen RL, van der Horst G, et al. 2002. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143:1545-1553.
31. Doane KJ, Birk DE. 1991. Fibroblasts retain their tissue phenotype when grown in three-dimensional collagen gels. Exp Cell Res 195:432-442.
32. Duffy FJ Jr, Seiler JG, Gelberman RH, Hergrueter CA. 1995. Growth factors and canine flexor tendon healing: initial studies in uninjured and repair models. J Hand Surg [Am] 20:645-649.
33. Duprez DM, Coltey M, Amthor H, et al. 1996. Bone morphogenetic protein-2 (BMP-2) inhibits muscle development and promotes cartilage formation in chick limb bud cultures. Dev Biol 174: 448-452.
34. Eblaghie MC, Lunn JS, Dickinson RJ, et al. 2003. Negative feedback regulation of FGF signaling levels by Pyst1/ MKP3 in chick embryos. Curr Biol 13: 1009-1018.
35. Edom-Vovard F, Bonnin MA, Duprez D. 2001a. Misexpression of Fgf-4 in the chick limb inhibits myogenesis by down-regulating Frek expression. Dev Biol 233:56-71.
36. Edom-Vovard F, Bonnin M, Duprez D. 2001b. Fgf8 transcripts are located in tendons during embryonic chick limb development. Mech Dev 108:203-206.
37. Edom-Vovard F, Schuler B, Bonnin MA, et al. 2002. Fgf4 positively regulates scleraxis and tenascin expression in chick limb tendons. Dev Biol 247:351-366.
38. Edom-Vovard F, Duprez D. 2004. Signals regulating tendon formation during chick embryonic development. Dev Dyn 229:449-457.
39. Ewart AK, Morris CA, Atkinson D, et al. 1993. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat Genet 5:11-16.
40. Eyre DR, Shapiro FD, Aldridge JF. 1985. A heterozygous collagen defect in a variant of the Ehlers-Danlos syndrome type VII. Evidence for a deleted aminotelopeptide domain in the pro-alpha 2(1) chain. J Biol Chem 260:11322-11329.
41. Fichard A, Chanut-Delalande H, Ruggiero F. 2003. [The Ehlers-Danlos syndrome: the extracellular matrix scaffold in question]. Med Sci (Paris) 19:443-452.
42. Font B, Eichenberger D, Rosenberg LM, van der Rest M. 1996. Characterization of the interactions of type XII collagen with two small proteoglycans from fetal bovine tendon, decorin and fibromodulin. Matrix Biol 15:341-348.
43. Gajko-Galicka A. 2002. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans. Acta Biochim Pol 49:433-441.
44. Galicka A, Wolczynski S, Gindzienski A. 2002. Comparative studies of osteoblast and fibroblast type I collagen in a patient with osteogenesis imperfecta type IV. J Pathol 196:235-237.
45. Garciadiego-Càzares D, Rosales C, Katoh M, Chimal-Monroy J. 2004. Coordination of chondrocyte differentiation and joint formation by alpha5beta1 integrin In the developing appendicular skeleton. Development 131:4735-4742.
46. Germain DP, Herrera-Guzman Y. 2004. Vascular Ehlers-Danlos syndrome. Ann Genet 47:1-9.
47. Gigante A, Chillemi C, Greco F. 1999. Changes of elastic fibers in musculoskeletal tissues of Marfan syndrome: a possible mechanism of joint laxity and skeletal overgrowth. J Pediatr Orthop 19:283-288.
48. Gong Y, Krakow D, Marcelino J, et al. 1999. Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet 21: 302-304.
49. Graham JM Jr, Stephens TD, Siebert JR, Smith DW. 1982. Determinants in the morphogenesis of muscle tendon insertions. J Pediatr 101:825-831.
50. Grahame R, Pyeritz RE. 1995. The Marfan syndrome: joint and skin manifestations a re prevalent and correlated. Br J Rheumatol 34:126-131.
51. Guo X, Day TF, Jiang X, et al. 2004. Wnt/beta-catenin signaling is sufficient and necessary for synovial joint formation. Genes Dev 18:2404-2417.
52. Gupta PA, Putnam EA, Carmical SG, et al. 2002. Ten novel FBN2 mutations in congenital contractural arachnodactyly: delineation of the molecular pathogenesis and clinical phenotype. Hum Mutat 19:39-48.
53. Hartmann C, Tabin CJ. 2001. Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell 104:341-351.
54. Hildebrand KA, Frank CB, Hart DA. 2004. Gene intervention in ligament and tendon: current status, challenges, future directions. Gene Ther 11:368-378.
55. Hsu C, Chang J. 2004. Clinical implications of growth factors in flexor tendon wound healing. J Hand Surg [Am] 29:551-563.
56. Hurle JM, Ros MA, Ganan Y, et al. 1990. Experimental analysis of the role of ECM in the patterning of the distal tendons of the developing limb bud. Cell Differ Dev 30:97-108.
57. Hyland J, Ala-Kokko L, Royce P, et al. 1992. A homozygous stop codon in the lysyl hydroxylase gene in two siblings with Ehlers-Danlos syndrome type VI. Nat Genet 2:228-231.
58. Imamura Y, Scott IC, Greenspan DS. 2000. The pro-alpha3(V) collagen chain. Complete primary structure, expression domains in adult and developing tissues, and comparison to the structures and expression domains of the other types V and XI procollagen chains. J Biol Chem 275:8749-8759.
59. Kalcheim C, Ben-Yair R. 2005. Cell rearrangements during development of the somite and its derivatives. Curr Opin Genet Dev 15:371-380.
60. Kardon G. 1998. Muscle and tendon morphogenesis in the avian hind limb. Development 125:4019-4032.
61. Kawakami Y, Rodriguez-Leon J, Koth CM, et al. 2003. MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb. Nat Cell Biol 5:513-519.
62. Keene DR, Sakai LY, Bachinger HP, Burgeson RE. 1987. Type III collagen can be present on banded collagen fibrils regardless of fibril diameter. J Cell Biol 105:2393-2402.
63. Kieny M, Chevallier A. 1979. Autonomy of tendon development in the embryonic chick wing. J Embryol Exp Morphol 49:153-165.
64. Komori T, Yagi H, Nomura S, et al. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
65. Kuc IM, Scott PG. 1997. Increased diameters of collagen fibrils precipitated in vitro in the presence of decorin from various connective tissues. Connect Tissue Res 36:287-296.
66. Lee J, Harwood FL, Akeson WH, Amiel D. 1998. Growth factor expression in healing rabbit medial collateral and anterior cruciate ligaments. Iowa Orthop J 18:19-25.
67. Liechty KW, MacKenzie TC, Shaaban AF, et al. 2000. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6:1282-1286.
68. Lou J, Tu Y, Burns M, et al. 2001. BMP-12 gene transfer augmentation of lacerated tendon repair. J Orthop Res 19: 1199-1202.
69. Lovinescu I, Koyama E, Pacifici M. 2003. Roles of FGF-10 on the development of diathrodial limb joints. Penn Dent J (Phila) 103:5, 9.
70. Macias D, Ganan Y, Sampath TK, et al. 1997. Role of BMP-2 and OP-1 (BMP-7) in programmed cell death and skeletogenesis during chick limb development. Development 124:1109-1117.
71. Mao JR, Bristow J. 2001. The Ehlers-Danlos syndrome: on beyond collagens. J Clin Invest 107:1063-1069.
72. McKiernan FE. 2005. Musculoskeletal manifestations of mild osteogenesis imperfecta in the adult. Osteoporos Int (in press).
73. Merino R, Rodriguez-Leon J, Macias D, et al. 1999. The BMP antagonist Gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limb. Development 126:5515-5522.
74. Mikic B, Schalet BJ, Clark RT, et al. 2001. GDF-5 deficiency in mice alters the ultrastructure, mechanical properties and composition of the Achilles tendon. J Orthop Res 19:365-371.
75. Mirzayan R, Cepkinian V, Yu J, et al. 2000. Skewfoot in patients with osteogenesis imperfecta. Foot Ankle Int 21:768-771.
76. Misof K, Landis WJ, Klaushofer K, Fratzl P. 1997. Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress. J Clin Invest 100:40-45.
77. Mizuguchi T, Collod-Beroud G, Akiyama T, et al. 2004. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet 36:855-860.
78. Molloy T, Wang Y, Murrell G. 2003. The roles of growth factors in tendon and ligament healing. Sports Med 33:381-394.
79. Nakamura N, Shino K, Natsuume T, et al. 1998. Early biological effect of in vivo gene transfer of platelet-derived growth factor (PDGF)-B into healing patellar ligament. Gene Ther 5:1165-1170.
80. Nakamura N, Hart DA, Boorman RS, et al. 2000. Decorin antisense gene therapy improves functional healing of early rabbit ligament scar with enhanced collagen fibrillogenesis in vivo. J Orthop Res 18:517-523.
81. Niederreither K, D'Souza R, Metsaranta M, et al. 1995. Coordinate patterns of expression of type I and III collagens during mouse development. Matrix Biol 14:705-713.
82. Nuytinck L, Freund M, Lagae L, et al. 2000. Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen. Am J Hum Genet 66:1398-1402.
83. O'Hagan RC, Tozer RG, Symons M, et al. 1996. The activity of the Ets transcription factor PEA3 is regulated by two distinct MARK cascades. Oncogene 13: 1323-1333.
84. O'Hagan RC, Hassell JA. 1998. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase. Oncogene 16:301-310.
85. Otto F, Thornell AP, Crompton T, et al. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
86. Oz B, Olmez N, Memis A. 2005. Osteogenesis imperfecta: a case with hand deformities. Clin Rheumatol.
87. Palmeri S, Mari F, Meloni I, et al. 2003. Neurological presentation of Ehlers-Danlos syndrome type IV in a family with parental mosaicism. Clin Genet 63:510-515.
88. Pasquali M, Still MJ, Vales TBoil, et al. 1997. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI. Proc Assoc Am Physicians 109: 33-41.
89. Penner AS, Rock MJ, Kielty CM, Shipley JM. 2002. Microfibril-associated glycoprotein-2 interacts with fibrillin-1 and fibrillin-2 suggesting a role for MAGP-2 in elastic fiber assembly. J Biol Chem 277:35044-35049.
90. Pittenger MF, Mackay AM, Beck SC, et al. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
91. Reinboth BJ, Finnis ML, Gibson MA, et al. 2000. Developmental expression of dermatan sulfate proteoglycans in the elastic bovine nuchal ligament. Matrix Biol 19:149-162.
92. Ritty TM, Ditsios K, Starcher BC. 2002. Distribution of the elastic fiber and associated proteins in flexor tendon reflects function. Anat Rec 268:430-440.
93. Rosenbloom J, Abrams WR, Mecham R. 1993. Extracellular matrix 4: the elastic fiber. Faseb J 7:1208-1218.
94. Salingcarnboriboon R, Yoshitake H, Tsuji K, et al. 2003. Establishment of tendon-derived cell lines exhibiting pluripotent mesenchymal stem cell-like property. Exp Cell Res 287:289-300.
95. Sarafova AP, Choi H, Forlino A, et al. 1998. Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagen. Hum Mutat 11:395-403.
96. Schramm C, Solursh M. 1990. The formation of premuscle masses during chick wing bud development. Anat Embryol (Berl) 182:235-247.
97. Schweitzer R, Chyung JH, Murtaugh LC, et al. 2001. Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development 128:3855-3866.
98. Settle SH Jr, Rountree RB, Sinha A, et al. 2003. Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes. Dev Biol 254:116-130.
99. Shimomura T, Jia F, Niyibizi C, Woo SL. 2003. Antisense oligonucleotides reduce synthesis of procollagen alpha1 (V) chain in human patellar tendon fibroblasts: potential application in healing ligaments and tendons. Connect Tissue Res 44:167-172.
100. Sini P, Denti A, Tira ME, Balduini C. 1997. Role of decorin on in vitro fibrillogenesis of type I collagen. Glycoconj J 14: 871-874.
101. Smith TG, Sweetman D, Patterson M, et al. 2005. Feedback interactions between MKP3 and ERK MAP kinase control scleraxis expression and the specification of rib progenitors in the developing chick somite. Development 132:1305-1314.
102. Storm EE, Huynh TV, Copeland NG, et al. 1994. Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature 368:639-643.
103. Tamamura Y, Otani T, Kanatani N, et al. 2005. Developmental regulation of Wnt/ beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J Biol Chem 280:19185-19195.
104. Thomas JT, Lin K, Nandedkar M, et al. 1996. A human chondrodysplasia due to a mutation in a TGF-beta superfamily member. Nat Genet 12:315-317.
105. Thomas JT, Kilpatrick MW, Lin K, et al. 1997. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 17:58-64.
106. Tontonoz P, Hu E, Graves RA, et al. 1994. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8:1224-1234.
107. Tsubone T, Moran SL, Amadio PC, et al. 2004. Expression of growth factors in canine flexor tendon after laceration in vivo. Ann Plast Surg 53:393-397.
108. Vogel A, Holbrook KA, Steinmann B, et al. 1979. Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome. Lab Invest 40:201-206.
109. Volk T. 1999. Singling out Drosophila tendon cells: a dialogue between two distinct cell types. Trends Genet 15:448-453.
110. Vunjak-Novakovic G, Altman G, Horan R, Kaplan DL. 2004. Tissue engineering of ligaments. Annu Rev Biomed Eng 6:131-156.
111. Walchli C, Koch M, Chiquet M, et al. 1994. Tissue-specific expression of the fibril-associated collagens XII and XIV. J Cell Sci 107:669-681.
112. Weintraub H, Davis R, Tapscott S, et al. 1991. The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251:761-766.
113. Wenstrup RJ, Florer JB, Cole WG, et al. 2004. Reduced type I collagen utilization: a pathogenic mechanism in COL5A1 haplo-insufficient Ehlers-Danlos syndrome. J Cell Biochem 92:113-124.
114. Wolfman NM, Hattersley G, Cox K, et al. 1997. Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family. J Clin Invest 100:321-330.
115. Yanagisawa H, Davis EC, Starcher BC, et al. 2002. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 415:168-171.
116. Yokouchi Y, Sasaki H, Kuroiwa A. 1991. Homeobox gene expression correlated with the bifurcation process of limb cartilage development. Nature 353:443-445.
117. Young RG, Butler DL, Weber W, et al. 1998. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 16:406-413.
118. Zanetti M, Braghetta P, Sabatelli P, et al. 2004. EMILIN-1 deficiency induces elastogenesis and vascular cell defects. Mol Cell Biol 24:638-650.
119. Zhang G, Young BB, Ezura Y, et al. 2005. Development of tendon structure and function: Regulation of collagen fibrillogenesis. J Musculoskelet Neuronal Interact 5:5-21.
120. Zweers MC, Bristow J, Steijlen PM, et al. 2003. Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome. Am J Hum Genet 73:214-217.
121. Zweers MC, van Vlijmen-Willems IM, van Kuppevelt TH, et al. 2004. Deficiency of tenascin-X causes abnormalities in dermal elastic fiber morphology. J Invest Dermatol 122:885-891.
122. Zweers MC, Dean WB, van Kuppevelt TH, et al. 2005. Elastic fiber abnormalities in hypermobility type Ehlers-Danlos syndrome patients with tenascin-X mutations. Cli Genet 67:330-334.